Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
During the 1980s, the Diabetes Control & Complications Trial (DCCT) began, seeking to determine whether intensive blood sugar control would help reduce long-term complications such as vision loss,…
Researchers at the University of Cambridge announced the successful creation of artificial sperm and eggs using human stem cells and skin cells. With specific genetic instructions, a small…
Millions of people spend the duration of their work day sitting in front of a computer, but few people understand the health detriments that extensive sitting causes. When…
Will this be the way you access your medical records in the future? The Cicret Bracelet may be the next breakthrough in the tech space, allowing users to…
As infectious bugs grow stronger and more resistant to drugs, a British Government Commission Review warned that these “superbugs” could lead to as many as 10 million deaths by…
Xavier Pi-Sunyer, MD, MPH and Steven Edelman, MD discuss the differences in A1C reduction when using GLP-1 receptor agonists versus DPP-4 inhibitors. GLP-1 receptor agonists have a larger reduction in A1C…
“Adverse drug reactions are a common cause of anaesthetic-related morbidity and mortality in healthy patients. They include drug intolerance or immune-mediated reactions, including anaphylaxis. Allergic anaphylaxis has an…
Xavier Pi-Sunyer, MD, MPH describes how physicians can make the decision between whether to prescribe an injectable GLP-1 agonist treatment or an oral DPP-4 inhibitor when seeking to lower…
Xavier Pi-Sunyer, MD, MPH, discusses incretin therapy, a treatment which increases insulin secretion in type 2 diabetes patients. According to Pi-Sunyer, GLP-1 can be raised in the blood…
Ajay Verma, MD, PhD, Vice President, Translational Neurology, Biogen Inc., assesses the neurodegeneration problem that will accompany the significant increase in the elderly population. He discusses the imminent intersection…
